University HealthSystem Consortium and VHA Inc. will distribute North American Scientific’s Prospera brachytherapy products to its member hospitals, North American Scientific said. The contract will become effective on July 15, 2006. The company was one of only two manufacturers to offer brachytherapy products. L. Michael Cutrer, president and CEO of North American Scientific said the deal shows that there is a growing acceptance of Prospera, which is used to treat prostate cancer.
North American Scientific Announces Distribution Deal